Confident mold identification for faster contamination investigations
Mold identification is a persistent challenge for pharmaceutical manufacturers and is a critical component of the quality control process. Mold contamination can cause significant issues for manufacturers and patients, including:
- Increased patient safety risks
- Lengthy and resource-intensive investigations
- Costly product recalls
- Regulatory and compliance risks
- Reduced operational efficiency
This makes the rapid and accurate identification of fungal contaminants essential to help pharmaceutical manufacturers ensure the safety and quality of their products.
Aligning With Regulatory Requirements
Microbial identification is a cornerstone of pharmaceutical quality control, ensuring product safety and compliance with regulatory standards. According to EU GMP Annex 1, Chapter 9.31, and USP <1113> guidance, manufacturers are required to identify microorganisms, including mold, to the species level when investigating contamination or monitoring environmental trends.
This level of precision is critical, as genus-level identification may overlook strain-specific risks such as pathogenicity, resistance profiles, and spoilage potential.
Maximizing Lab Efficiency With MALDI-TOF Technology
Modern technologies like MALDI-TOF mass spectrometry, offer rapid, accurate, and cost-effective species-level identification, making them ideal for routine use in industrial quality control.
VITEK® MS PRIME, our new-generation mass spectrometry microbial identification system, exemplifies this advancement, providing robust microbial identification capabilities that align with regulatory expectations and support contamination control strategies.
Standardized, ready-to-use reagents, including mold protocols, are validated for peace of mind, so manufacturers can save time and money by bringing the species-level identification of mold contaminants in-house. The system delivers enhanced laboratory efficiency and a range of benefits, including:
- Up to 48 identifications per slide in < 20 minutes, for a max. of 768 identifications per run
- Benchtop system for easy lab integration
- User-friendly interface and efficient workflow
- Continuous load-and-go and slide prioritization capabilities for full lab flexibility
- Greater lab autonomy with automated fine-tuning
- LIMS compatibility for data tracking and compliance
- 21 CFR Part 11 enabled software
A comparative evaluation
In a recent study, VITEK® MS PRIME was comparatively evaluated for mold identification against the most commonly used sequencing-based identification platform for pharmaceutical quality control. To simulate real-world conditions, 31 molds provided by pharmaceutical manufacturers were sequenced and tested in triplicate using VITEK® MS PRIME, and results found that:
VITEK® MS PRIME yielded better or equivalent results in 87% of instances.
- VITEK® MS PRIME yielded better results over sequencing in 13 instances
- VITEK® MS PRIME yielded equivalent results in 14 instances
- Sequencing only yielded a better result in 1 instance
In addition to outperforming sequencing in accuracy, it also had a simpler workflow and a faster turnaround time, making it ideal for routine industrial use.
Streamlined Workflow, Prime Results
With recent regulatory updates, including cGMP and USP <1113>, species-level mold identification is now a critical requirement for pharmaceutical quality control investigations. Genus-level identification is no longer sufficient when microorganisms are identified at atypically high rates, exceed alert limits, or are linked to sterility failures.
By integrating VITEK® MS PRIME into their quality control workflows, pharmaceutical manufacturers gain a rapid, reliable, and regulatory-compliant identification solution that helps accelerate investigations, strengthen contamination control, and safeguard product integrity.
Get in touch with our experts to learn how our microbial identification solutions can help streamline your workflow and bring species-level identification in-house.
